~~<i id='DEFB66CCA0'><strike id='DEFB66CCA0'><tt id='DEFB66CCA0'><pre id='DEFB66CCA0'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

Wikipedia

author：fashion 2025-08-04 03:41:49 - browse：812

Two Vertex buidings in the Seaport District — David L Ryan/Globe Staff

When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

Now, Vertex may be on the move again.

With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： The (many) problems with a new study criticizing cancer screening

focus

Wikipedia

explore

focus

AdobeWhileit’swidelyacceptedthatthepharmaindustryisinnovativeinR&D,itisalsotruethatitcanbeslowat

WSS

Why Novartis is changing the name of its research labs

The problems with dementia villages

What drug price negotiations mean for Medicare Part D

STAT Summit: Ending the crisis of Black deaths in the U.S.

How AI can help patients find reliable information about doctors

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

focus

Wikipedia

focus

ChatGPT in medicine: STAT answers readers' burning questions

Advances in CAR

As demand for Covid shots wanes, Moderna seeks its next success

How to protect patients from sexual assault

Hollywood unions extend contract negotiations for actors

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Jerome Adams on the need for new antivirals for Covid

Medicaid rebukes states for mistakenly disenrolling children

DIEP, the 'gold standard' of breast reconstruction, is under threat

STAT Summit: How researchers deal with rejection

focus

STAT Summit: How researchers deal with rejection

Questions loom on AstraZeneca cancer drug as safety concerns ebb

FDA clears Verve to begin U.S. study of gene

What American doctors can learn from their Israeli counterparts

What drug price negotiations mean for Medicare Part D

The 10 drugs up first for Medicare price negotiation

focus

Wikipedia

explore

focus